David A. Thorley‐Lawson

15.4k total citations · 4 hit papers
115 papers, 12.2k citations indexed

About

David A. Thorley‐Lawson is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, David A. Thorley‐Lawson has authored 115 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 43 papers in Immunology and 37 papers in Epidemiology. Recurrent topics in David A. Thorley‐Lawson's work include Viral-associated cancers and disorders (87 papers), Lymphoma Diagnosis and Treatment (35 papers) and Cytomegalovirus and herpesvirus research (33 papers). David A. Thorley‐Lawson is often cited by papers focused on Viral-associated cancers and disorders (87 papers), Lymphoma Diagnosis and Treatment (35 papers) and Cytomegalovirus and herpesvirus research (33 papers). David A. Thorley‐Lawson collaborates with scholars based in United States, United Kingdom and Ghana. David A. Thorley‐Lawson's co-authors include Gregory J. Babcock, Andrew Gross, L L Decker, Jaap M. Middeldorp, D. Michiel Pegtel, Lauri L. Laichalk, Karen P. Mann, Katherine Cosmopoulos, Erik Hopmans and Mark S. Volk and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

David A. Thorley‐Lawson

114 papers receiving 11.7k citations

Hit Papers

Functional delivery of viral miRNAs via exosomes 1998 2026 2007 2016 2010 2004 2001 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Functional delivery of viral miRNAs via exosomes
    2010 1.3k citations D. Michiel Pegtel, Katherine Cosmopoulos et al. Proceedings of the National Academy of Sciences profile →
  2. Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
    2004 760 citations David A. Thorley‐Lawson et al. profile →
  3. Epstein-Barr virus: exploiting the immune system
    2001 733 citations David A. Thorley‐Lawson Nature reviews. Immunology profile →
  4. EBV Persistence in Memory B Cells In Vivo
    1998 631 citations Gregory J. Babcock, L L Decker et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Thorley‐Lawson United States 59 8.1k 3.7k 3.6k 3.6k 2.4k 115 12.2k
Daniel M. Knowles United States 57 10.0k 1.2× 5.6k 1.5× 4.7k 1.3× 3.1k 0.9× 2.0k 0.9× 171 16.1k
Bill Sugden United States 59 8.7k 1.1× 3.3k 0.9× 4.2k 1.2× 2.1k 0.6× 4.2k 1.8× 147 13.4k
Joseph S. Pagano United States 66 8.4k 1.0× 2.4k 0.7× 4.6k 1.3× 3.2k 0.9× 3.8k 1.6× 244 14.3k
Gerald Niedobitek Germany 63 7.8k 1.0× 4.2k 1.1× 2.2k 0.6× 3.3k 0.9× 1.4k 0.6× 205 11.5k
Richard F. Ambinder United States 70 9.4k 1.2× 5.9k 1.6× 3.1k 0.9× 3.0k 0.8× 2.2k 0.9× 348 15.1k
Nancy Raab‐Traub United States 71 11.1k 1.4× 4.4k 1.2× 3.4k 0.9× 3.0k 0.8× 3.5k 1.5× 167 15.0k
Wolfgang Hammerschmidt Germany 59 6.5k 0.8× 2.4k 0.6× 3.7k 1.0× 2.6k 0.7× 2.1k 0.9× 136 9.5k
Kenzo Takada Japan 56 6.6k 0.8× 2.6k 0.7× 2.2k 0.6× 2.7k 0.8× 2.2k 0.9× 158 9.3k
George Miller United States 58 9.7k 1.2× 3.0k 0.8× 5.7k 1.6× 2.2k 0.6× 999 0.4× 196 12.2k
Barbara Ensoli Italy 62 5.4k 0.7× 1.8k 0.5× 3.9k 1.1× 4.1k 1.1× 3.8k 1.6× 249 13.8k

Countries citing papers authored by David A. Thorley‐Lawson

Since Specialization
Citations

This map shows the geographic impact of David A. Thorley‐Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Thorley‐Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Thorley‐Lawson more than expected).

Fields of papers citing papers by David A. Thorley‐Lawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Thorley‐Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Thorley‐Lawson. The network helps show where David A. Thorley‐Lawson may publish in the future.

Co-authorship network of co-authors of David A. Thorley‐Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Thorley‐Lawson. A scholar is included among the top collaborators of David A. Thorley‐Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Thorley‐Lawson. David A. Thorley‐Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Awuah, P., et al.. (2014). A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis. PLoS Pathogens. 10(5). e1004170–e1004170. 72 indexed citations
2.
Qiu, Jin & David A. Thorley‐Lawson. (2014). EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proceedings of the National Academy of Sciences. 111(30). 11157–11162. 56 indexed citations
3.
Hawkins, Jared B., Edgar Delgado‐Eckert, David A. Thorley‐Lawson, & Michael Shapiro. (2013). The Cycle of EBV Infection Explains Persistence, the Sizes of the Infected Cell Populations and Which Come under CTL Regulation. PLoS Pathogens. 9(10). e1003685–e1003685. 30 indexed citations
4.
Pegtel, D. Michiel, Katherine Cosmopoulos, David A. Thorley‐Lawson, et al.. (2010). Functional delivery of viral miRNAs via exosomes. Proceedings of the National Academy of Sciences. 107(14). 6328–6333. 1330 indexed citations breakdown →
5.
Shapiro, Michael, et al.. (2009). The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output. PLoS Pathogens. 5(7). e1000496–e1000496. 196 indexed citations
6.
Cosmopoulos, Katherine, D. Michiel Pegtel, Jared B. Hawkins, et al.. (2008). Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma. Journal of Virology. 83(5). 2357–2367. 144 indexed citations
7.
Duca, Karen, Michael Shapiro, Edgar Delgado‐Eckert, et al.. (2007). A Virtual Look at Epstein–Barr Virus Infection: Biological Interpretations. PLoS Pathogens. 3(10). e137–e137. 27 indexed citations
8.
Stollar, B. David, et al.. (2007). Influence of EBV on the Peripheral Blood Memory B Cell Compartment. The Journal of Immunology. 179(5). 3153–3160. 42 indexed citations
9.
Catalina, Michelle D., et al.. (2004). Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells. Journal of Virology. 78(10). 5194–5204. 121 indexed citations
10.
Thorley‐Lawson, David A.. (2001). Epstein-Barr virus: exploiting the immune system. Nature reviews. Immunology. 1(1). 75–82. 733 indexed citations breakdown →
11.
Joseph, Alexandra, Gregory J. Babcock, & David A. Thorley‐Lawson. (2000). EBV Persistence Involves Strict Selection of Latently Infected B Cells. The Journal of Immunology. 165(6). 2975–2981. 79 indexed citations
12.
Babcock, Gregory J., L L Decker, Richard B. Freeman, & David A. Thorley‐Lawson. (1999). Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients. The Journal of Experimental Medicine. 190(4). 567–576. 257 indexed citations
13.
Babcock, Gregory J., L L Decker, Mark S. Volk, & David A. Thorley‐Lawson. (1998). EBV Persistence in Memory B Cells In Vivo. Immunity. 9(3). 395–404. 631 indexed citations breakdown →
14.
Johannessen, Ingólfur, et al.. (1997). Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells. Oncogene. 15(3). 275–283. 36 indexed citations
15.
Ianelli, Christopher J., C M Edson, & David A. Thorley‐Lawson. (1997). A ligand for human CD48 on epithelial cells. The Journal of Immunology. 159(8). 3910–3920. 11 indexed citations
16.
Decker, L L, Gulfaraz Khan, Richard B. Freeman, et al.. (1996). The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.. The Journal of Experimental Medicine. 184(1). 283–288. 214 indexed citations
17.
Thorley‐Lawson, David A., et al.. (1991). Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48).. Molecular and Cellular Biology. 11(3). 1614–1623. 16 indexed citations
18.
Hurley, Elizabeth A., John A. McNeil, Jeanne B. Lawrence, & David A. Thorley‐Lawson. (1990). Genomic Integration as a Novel Mechanism of EBV Persistence. Current topics in microbiology and immunology. 166. 367–374. 6 indexed citations
19.
Staunton, Donald E., Michelle M. LeBeau, Jeanne B. Lawrence, et al.. (1989). Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23.. The Journal of Experimental Medicine. 169(3). 1087–1099. 67 indexed citations
20.
Donohue‐Rolfe, Arthur, Gerald T. Keusch, C M Edson, David A. Thorley‐Lawson, & Mary Jacewicz. (1984). Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.. The Journal of Experimental Medicine. 160(6). 1767–1781. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel M. Knowles Breakdown of academic impact, for papers by Bill Sugden Breakdown of academic impact, for papers by Joseph S. Pagano Breakdown of academic impact, for papers by Gerald Niedobitek Breakdown of academic impact, for papers by Richard F. Ambinder Breakdown of academic impact, for papers by Nancy Raab‐Traub Breakdown of academic impact, for papers by Wolfgang Hammerschmidt Breakdown of academic impact, for papers by Kenzo Takada Breakdown of academic impact, for papers by George Miller Breakdown of academic impact, for papers by Barbara Ensoli
Rankless by CCL
2026